Please login to the form below

Not currently logged in

Omega buys pharmacy to understand customers

warman freed pharmacy

Will turn Warman-Freed in North London into ‘learning pharmacy’

FDA gives green light to Genzyme’s oral Gaucher drug

US regulator Food and Drug Administrator FDAOral therapy Cerdelga is set to complement intravenous Cerezyme

Illumina partners with pharma majors on cancer diagnostic

illumina logoWill work with AstraZeneca, Janssen and Sanofi to develop gene sequencing tool

BMS and Celgene to research cancer immunotherapy combo

Bristol Myers Squibb logoCompanies will study combination of nivolumab and Abraxane

MHRA launches online oral anticoagulation module

mhra logoAims to help healthcare professionals understand new blood clot treatments


Pharma jobs boost for Northern Ireland

Co. Armagh-based Almac Group is to create 348 jobs over the next five years

Brilinta bill of health boosts AstraZeneca

astrazeneca-brilinta-ticagrelorUS drops investigation into study data

Novartis licenses tuberculosis R&D to TB Alliance

Novartis buildingIncludes drugs to tackle resistant forms of the disease

UDG sells stake in UniDrug

UDG HealthcareAlliance Boots will take over full control of supply chain specialist

old world mapHistory rhymes: modern globalisation trends mirror the past

Recent events are an echo of the late 19th century

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Cmed Clinical Services

Cmed is a full service, global CRO specialized in the design and delivery of both innovative and traditional early phase...

Latest intelligence

3 Steps to Navigating Multichannel in Healthcare
You know about multichannel, but... where now? Download the 3 Steps to Navigating Multichannel in Healthcare ebook to learn what you should do next when planning your multichannel campaign....
Online Physician Communities
How can pharma develop a more customer-centric approach?
Business pressures and customer needs will force pharma to focus on multichannel marketing in the next few years...
Exploring MINT: Part 2 - Indonesia
In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...